Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+22.98%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$8.74B
AUM Growth
+$2.28B
(+35%)
Cap. Flow
+$939M
Cap. Flow
% of AUM
10.74%
Top 10 Holdings %
Top 10 Hldgs %
23.52%
Holding
1,049
New
43
Increased
781
Reduced
144
Closed
43
Top Buys
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$52.4M |
| 2 |
Microsoft
MSFT
|
$49M |
| 3 |
iShares MBS ETF
MBB
|
$47.2M |
| 4 |
Home Depot
HD
|
$35.9M |
| 5 |
Apple
AAPL
|
$31.9M |
Top Sells
| 1 |
Planet Fitness
PLNT
|
$22.8M |
| 2 |
McDonald's
MCD
|
$14.3M |
| 3 |
AGN
Allergan plc
AGN
|
$11.8M |
| 4 |
Ulta Beauty
ULTA
|
$11.8M |
| 5 |
Align Technology
ALGN
|
$10.2M |
Sector Composition
| 1 | Technology | 22.36% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 10.93% |
| 5 | Communication Services | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
876
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $221K | ﹤0.01% |
+2,076
| New | +$221K |
|
877
CRISPR Therapeutics
CRSP
$4.99B
| $220K | ﹤0.01% |
2,999
+389
| +15% | +$28.5K |
|
878
Saic
SAIC
$4.83B
| $219K | ﹤0.01% |
2,822
-732
| -21% | -$56.8K |
|
|
SAFE
879
DELISTED
Safehold Inc.
SAFE
| $218K | ﹤0.01% |
3,786
+530
| +16% | +$30.5K |
|
|
TECX
880
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $217K | ﹤0.01% |
+1,035
| New | +$217K |
|
881
Q32 Bio
QTTB
$20.4M
| $216K | ﹤0.01% |
791
+102
| +15% | +$27.9K |
|
882
Bath & Body Works
BBWI
$6.06B
| $214K | ﹤0.01% |
17,669
-291,561
| -94% | -$3.53M |
|
883
Twist Bioscience
TWST
$1.55B
| $214K | ﹤0.01% |
+4,731
| New | +$214K |
|
|
GAP
884
The Gap, Inc.
GAP
$8.83B
| $214K | ﹤0.01% |
16,987
-23,460
| -58% | -$296K |
|
885
AngioDynamics
ANGO
$436M
| $213K | ﹤0.01% |
20,978
+6,295
| +43% | +$63.9K |
|
|
NXRT
886
NexPoint Residential Trust
NXRT
$879M
| $213K | ﹤0.01% |
6,015
+122
| +2% | +$4.32K |
|
887
Rocket Pharmaceuticals
RCKT
$354M
| $210K | ﹤0.01% |
10,020
-1,542
| -13% | -$32.3K |
|
888
Editas Medicine
EDIT
$248M
| $208K | ﹤0.01% |
7,040
-100
| -1% | -$2.96K |
|
889
Ultragenyx Pharmaceutical
RARE
$3.07B
| $208K | ﹤0.01% |
2,660
-2,014
| -43% | -$157K |
|
890
Intellia Therapeutics
NTLA
$1.29B
| $206K | ﹤0.01% |
9,817
-2,085
| -18% | -$43.8K |
|
891
Tanger
SKT
$3.94B
| $203K | ﹤0.01% |
28,465
+4,039
| +17% | +$28.8K |
|
892
Adverum Biotechnologies
ADVM
$73.9M
| $202K | ﹤0.01% |
967
-854
| -47% | -$178K |
|
|
TNAV
893
DELISTED
Telenav Inc.
TNAV
| $201K | ﹤0.01% |
36,528
+701
| +2% | +$3.86K |
|
|
BLUE
894
DELISTED
bluebird bio
BLUE
| $200K | ﹤0.01% |
253
+67
| +36% | +$53K |
|
|
BEST
895
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $200K | ﹤0.01% |
2,331
+871
| +60% | +$74.7K |
|
|
AEGN
896
DELISTED
Aegion Corp
AEGN
| $198K | ﹤0.01% |
12,455
+3,314
| +36% | +$52.7K |
|
897
Xencor
XNCR
$610M
| $197K | ﹤0.01% |
6,094
+1,366
| +29% | +$44.2K |
|
898
Codexis
CDXS
$218M
| $196K | ﹤0.01% |
17,179
+5,246
| +44% | +$59.9K |
|
899
Infosys
INFY
$67.9B
| $195K | ﹤0.01% |
20,210
-9,163
| -31% | -$88.4K |
|
900
Xerox
XRX
$493M
| $194K | ﹤0.01% |
12,674
-28,091
| -69% | -$430K |
|